logo
Select company
Select metric
$ 947.47MShareholders Equity
VS
Market
66
Sector
86
Industry
95
History
42
$ 5.78Close
$ 4.28 - $ 12.48 52-Week Range
Ticker Information

Ticker

VIR

Company Name

VIR BIOTECHNOLOGY INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

VIR BIOTECHNOLOGY INC - Shareholders Equity Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

VIR - Equity Historical data
DateShareholders Equity
6/30/2025$ 947.47M
3/31/2025$ 1.04B
12/31/2024$ 1.15B
9/30/2024$ 1.24B
6/30/2024$ 1.43B
3/31/2024$ 1.55B
12/31/2023$ 1.59B
9/30/2023$ 1.68B
6/30/2023$ 1.81B
3/31/2023$ 1.97B
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • VIR BIOTECHNOLOGY INC's latest trailing twelve months (TTM) Equity stands at $ 812.36M.
  • Over the past 5 years, VIR BIOTECHNOLOGY INC's average Equity has been $ 1.39B.
  • The median Equity for VIR BIOTECHNOLOGY INC during this period was $ 1.43B
  • VIR BIOTECHNOLOGY INC reached its highest Equity over the past 5 years at $ 2.15B.
  • The lowest Equity recorded by VIR BIOTECHNOLOGY INC in the same timeframe $ 650.95M

VIR BIOTECHNOLOGY INC's Equity vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Equity Benchmarks
CompanyEquity
ABUS : ARBUTUS BIOPHARMA CORP $ 82.98MZBIO : ZENAS BIOPHARMA INC $ 239.63MBCYC : BICYCLE THERAPEUTICS PLC $ 668.91MQURE : UNIQURE NV $ -4MTNGX : TANGO THERAPEUTICS INC $ 134.95MNUVB : NUVATION BIO INC $ 372.91MALMS : ALUMIS INC $ 485.33MIMNM : IMMUNOME INC $ 269.27MTSHA : TAYSHA GENE THERAPIES INC $ 248.73MRLAY : RELAY THERAPEUTICS INC $ 665.66M

Definition of Shareholders Equity

[Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.

VIR - Shareholders Equity, Last 5 years

$ 650.95M

Minimum

Mar 31, 2021

$ 2.15B

Maximum

Sep 30, 2022

$ 1.39B

Average

$ 1.43B

Median

Equity Benchmark Analysis

The chart above depicts the distribution of Equity for companies in the Total Stock Market. The average Equity of the companies is $ 384M with a standard deviation of $ 548.41M.
The following table provides additional summary stats:
Equity in the Market:
filtered constituents3.47K
min$ -1.4B
max$ 2.14B
average$ 384M
median$ 165.72M
std$ 548.41M